Bayer、ECR 2026で低用量MRI造影剤gadoquatrane第3相データ発表へ──ガドリニウム用量60％削減 | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

Bayer to present new Phase III data for the investigational low-dose MRI contrast agent gadoquatrane at ECR 2026, featuring a 60% reduction in gadolinium dose.

stellanews.life/technology/8...

#MRI #Radiology #Bayer #ECR2026 #Gadoquatrane #Phase3 #MedicalImaging #ContrastAgent

New material to make MRI contrast agents greener, safer, sharper Scientists at Oregon State University (OSU) have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic t...

Metal-organic frameworks (MOFs) serve as the basis for a novel type of #MRI #ContrastAgent, which the developers led by 🇺🇸 @oregonstate.edu hope can outperform current agents while being less toxic for the patient. #Radiology

🦠🔦 A new, #bacteria-based contrast agent illuminates #tumors like a neon sign during #surgery, enabling more precise resection and reducing the risk of recurrence. #contrastagent http://dlvr.it/TM73Ts

ESUR updates advice on hypersensitivity reactions to contrast media The European Society of Urogenital Radiology (ESUR) has updated its guidelines on the management of hypersensitivity reactions to contrast media.

The European Society of #Urogenital #Radiology has updated its practice guidelines on management of hypersensitivity reactions to contrast media. Go to our report: buff.ly/W0pH3Fq #ContrastAgent

Did you know that MRI scans can sometimes leave traces of toxic metals in the body? Recent research shows that gadolinium, a metal used in MRI contrast agents
#MRI #Healthcare #PatientSafety #Radiology #MedicalResearch #Gadolinium #ContrastAgent #HealthAwareness

Heimer et al. demonstrate in a preclinical study that a #TantalumOxide–based nanoparticle #ContrastAgent showed higher hepatic contrast enhancement and improved the detection of #HepaticTumors in #ComputedTomography. #UCSFimaging #LMUradiology

doi.org/10.1097/rli....

Heimer at al. show that a novel intravenous #Tantalum oxide nanoparticle #ContrastAgent provides contrast advantages compared to #Iopamidol for improved visualization of thoracic arteries and veins in a multiphase #CT protocol. #LMUradiology #UCSFimaging

t.co/cNCylQophB

New dual PET/MRI contrast agent to enhance kidney diagnostics A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can be used in both magnetic resonance imaging (MRI) and positron emission tomography (PET).

Researchers led by 🇨🇿 @iocbprague.bsky.social, with 🇩🇪 @unituebingen.bsky.social have developed a new type of #contrastagent for use in both #MRI and #PET imaging has the potential to significantly enhance diagnosis and subsequent treatment, particularly for #kidney diseases and tumors.

Scientists @leibnizFMP led by Leif Schröder demonstrate new contrast agent for early diagnosis of brain metastases, using synthetic molecule that helps to detect the formation of new blood vessels for more sophisticated imaging https://t.co/Dl3NqvtuiH #contrastagent #imaging